Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study

The risk of relapse for early breast cancer (BC) patients persists even after decades and to date, no specific and sensitive effective circulating biomarker for recurrence prediction has been identified yet. The international guidelines do not recommend the assessment of the serum tumor markers CEA...

Descripción completa

Detalles Bibliográficos
Autores principales: Maltoni, Roberta, Balzi, William, Rossi, Tania, Fabbri, Francesco, Bravaccini, Sara, Montella, Maria Teresa, Massa, Ilaria, Bertoni, Lucia, Falcini, Fabio, Altini, Mattia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870402/
https://www.ncbi.nlm.nih.gov/pubmed/35200539
http://dx.doi.org/10.3390/curroncol29020039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870402/
https://www.ncbi.nlm.nih.gov/pubmed/35200539
http://dx.doi.org/10.3390/curroncol29020039

Ejemplares similares